von Willebrand Disease and Pregnancy

References

• von Willebrand E A. Hereditary pseudohaemophilia. Haemophilia 1999
   Google Scholar
• Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454–459
   PubMed Web of Science ®Google Scholar
• Castaman G, Eikenboom J C, Bertina R M, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065–1070
   PubMed Web of Science ®Google Scholar
• Werner E J, Broxson E H, Tucker E L, Giroux D S, Shults J, Abshire T C. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893–898
   PubMed Web of Science ®Google Scholar
• Kadir R AED, Sabin C A, Owens D, Lee C A. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485–489
   PubMed Web of Science ®Google Scholar
• Lusher J M. Systemic causes of excessive uterine bleeding. Semin Hematol 1999; 36: 10–20
   Google Scholar
• Claessens E A, Cowell C A. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 1981; 28: 369–378
   Google Scholar
• Kadir R AED, Sabin C A, Pollard D, Lee C A. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40–48
   PubMed Web of Science ®Google Scholar
• Lee C A. Women and inherited bleeding disorders: menstrual issues. Semin Hematol 1999; 36: 21–27
   PubMed Web of Science ®Google Scholar
• Kadir R A, Sabin C A, Pollard D, Lee C A, Economides D L. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4: 836–841
   PubMed Web of Science ®Google Scholar
• Foster P A. The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 784–790
   PubMedGoogle Scholar
• Weiss H J, Sussman I I, Hoyer L W. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390–404
   PubMed Web of Science ®Google Scholar
• Ruggeri Z M, De Marco L, Gatti L, Bader R, Montgomery R R. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 1–12
   PubMed Web of Science ®Google Scholar
• Fujimura Y, Titani K, Holland L Z, Russell S R, Roberts J R, Elder J H, Ruggeri Z M, Zimmerman T S. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein lb. J Biol Chem 1986; 261: 381–385
   PubMedGoogle Scholar
• Plow E F, Pierschbacher M D, Ruoslahti E, Marguerie G A, Ginsberg M H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057–8061
   PubMed Web of Science ®Google Scholar
• Ruggeri Z M. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611–616
   PubMed Web of Science ®Google Scholar
• Beguin S, Kumar R, Keularts I, Seligsohn U, Coller B S, Hemker H C. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564–570
   PubMed Web of Science ®Google Scholar
• Ginsburg D, Handin R I, Bonthron D T, Donlon T A, Bruns G A, Latt S A, Orkin S H. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401–1406
   PubMed Web of Science ®Google Scholar
• Bonthron D T, Handin R I, Kaufman R J, Wasley L C, Orr E C, Mitsock L M, Ewenstein B, Loscalzo J, Ginsburg D, Orkin S H. Structure of pre-provon Willebrand factor and its expression in heterologous cells. Nature 1986; 324: 270–273
   PubMed Web of Science ®Google Scholar
• Fowler W E, Fretto L J, Hamilton K K, Erickson H P, McKee P A. Substructure of human von Willebrand factor. J Clin Invest 1985; 76: 1491–1500
   PubMed Web of Science ®Google Scholar
• Wagner D D, Marder V J. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol 1984; 99: 2123–2130
   PubMed Web of Science ®Google Scholar
• Federici A B, Elder J H, De Marco L, Ruggeri Z M, Zimmerman T S. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest 1984; 74: 2049–2055
   Google Scholar
• Turecek P L, Pichler L, Auer W, Eder G, Varadi K, Mitterer A, Mundt W, Schlokat U, Domer F, Drouet L O, Roussi J, van Mourik J A, Schwarz H P. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease. Blood 1999; 94: 1637–1647
   Google Scholar
• van Mourik J ABR, Huisveld I A, Fijnvandraat K, Pajkrt D, van Genderen P J, Fijnheer R. von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179–185
   PubMed Web of Science ®Google Scholar
• Sussman I I, Rand J H. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. J Lab Clin Med 1982; 100: 526–532
   PubMedGoogle Scholar
• Ruggeri Z M, Zimmerman T S. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895–904
   PubMed Web of Science ®Google Scholar
• Federici A B, Mannucci P M. Optimizing therapy with factor VHI/von Willebrand factor concentrates in von Willebrand disease. Haemophilia 1998; 4: 7–10
   Google Scholar
• Zimmerman T S, Ruggeri Z M. von Willebrand disease. Hum Pathol 1987; 18: 140–152
   Google Scholar
• Rodgers G M. Overview of platelet physiology and laboratory evaluation of platelet function. Clin Obstet Gynecol 1999; 42: 349–359
   PubMed Web of Science ®Google Scholar
• Vischer U MdMP. von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol 1999; 30: 93–109
   Google Scholar
• Favaloro E J, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999; 62: 165–174
   PubMed Web of Science ®Google Scholar
• Fressinaud E, Veyradier A, Sigaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol 1999; 106: 777–783
   PubMed Web of Science ®Google Scholar
• Holmberg L, Nilsson I M. Von Willebrand disease. Clin Haematol 1985; 14: 461–488
   PubMedGoogle Scholar
• Weiss H J, Meyer D, Rabinowitz R, Pietu G, Girma J P, Vicic W J, Rogers J. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VHI/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 306: 326–333
   PubMed Web of Science ®Google Scholar
• Mannucci P M. Treatment of von Willebrand disease. Haemophilia 1998; 4: 661–664
   Google Scholar
• Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973; 238: 1–159
   PubMedGoogle Scholar
• Fausett B, Silver R M. Congenital disorders of platelet function. Clin Obstet Gynecol 1999; 42: 390–405
   Google Scholar
• Veyradier A, Jumilly A L, Ribba A S, Obert B, Houllier A, Meyer D, Girma J P. New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factor. Thromb Haemost 1999; 82: 134–139
   Google Scholar
• Mohlke K L, Nichols W C, Ginsburg D. The molecular basis of von Willebrand disease. Int J Clin Lab Res 1999; 29: 1–7
   Google Scholar
• Lankhof H DC, Schiphorst M E, Ijsseldijk M J, Bracke M, Furlan M, de Groot P G, Sixma J J, Vink T. Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease. Thromb Haemost 1999; 81: 976–983
   Google Scholar
• Takimoto Y. IF Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma. Int J Hematol 1999; 70: 127–131
   Google Scholar
• Pareti F I, Federici A B, Cattaneo M, Mannucci P M. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins lb and Ilb/IIIa. Br J Haematol 1990; 75: 86–91
   PubMed Web of Science ®Google Scholar
• Giles A R, Hoogendoorn H, Benford K. Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy. Br J Haematol 1987; 67: 349–353
   Google Scholar
• Valster F A, Feijen H L, Hutten J W. Severe thrombocytopenia in a pregnant patient with platelet-associated IgM, and known von Willebrand's disease; a case report. Eur J Obstet Gynecol Reprod Biol 1990; 36: 197–201
   Google Scholar
• Casonato A SM, Bertomoro A, Fede T, Vasoin F, Girolami A. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. Blood Coagul Fibrinolysis 1991; 2: 33–40
   Google Scholar
• Burrows R FKJ. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463–1466
   PubMed Web of Science ®Google Scholar
• Maharaj D, Walker I D, McEwan H P, Nisbet C E, Erskine J G. Coincidental Von Willebrands disease and immune thrombocytopenia in pregnancy: treatment with high dose intravenous immunoglobulin. Clin Lab Haematol 1986; 8: 227–231
   Google Scholar
• Miller C H, Kelley L, Green D. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Am J Hematol 1998; 58: 311–318
   Google Scholar
• Nesbitt I MHK, Preston F E, Peake I R, Goodeve A C. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations. Thromb Haemost 1999; 82: 1061–4
   Google Scholar
• Carter C BB. Acquired von Willebrand's disease in myeloproliferative syndrome: spontaneous remission during pregnancy. Thromb Haemost 1992; 67: 387–388
   PubMed Web of Science ®Google Scholar
• Aylesworth C ASR, Rick M E, Alving B M. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995; 50: 217–219
   PubMed Web of Science ®Google Scholar
• Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 1987; 18: 111–122
   PubMed Web of Science ®Google Scholar
• Mannucci P M. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449–1455
   PubMed Web of Science ®Google Scholar
• Zingg H H. Vasopressin and oxytocin receptors. Baillieres Clin Endocrinol Metab 1996; 10: 75–96
   PubMed Web of Science ®Google Scholar
• Lethagen S. Desmopressin in the treatment of women's bleeding disorders. Haemophilia 1999; 5: 233–237
   Google Scholar
• Smith T J, Gill J C, Ambruso D R, Hathaway W E. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 1989; 31: 199–202
   PubMed Web of Science ®Google Scholar
• Casonato A SA, Pontara E, Zucchetto A, Rossi C, De Marco L, Girolami A. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost 1999; 81: 224–228
   PubMed Web of Science ®Google Scholar
• Ieko M, Sakurama S, Sagawa A, Yoshikawa M, Satoh M, Yasukouchi T, Nakagawa S. Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers. Am J Hematol 1990; 35: 26–31
   Google Scholar
• Foster P A. A perspective on the use of FVIII concentrates and cryoprecipitate prophylacrically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1370–1378
   Google Scholar
• Chang A C, Rick M E, Ross Pierce L, Weinstein M J. Summary of a workshop on potency and dosage of von Willebrand factor concentrates. Haemophilia 1998; 4: 1–6
   Google Scholar
• Dobrkovska A, Krzensk U, Chediak J R. Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease. Haemophilia 1998; 4: 33–39
   PubMedGoogle Scholar
• Sadler J E. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395–424
   PubMed Web of Science ®Google Scholar
• Fischer B E. Recombinant von Willebrand factor: potential therapeutic use. J Thromb Thrombolysis 1999; 8: 197–205
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lindstedt M, Blomback M, Anvret M. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 1995; 96: 388–394
   Google Scholar
• Kadir R A, Lee C A, Sabin C A, Pollard D, Economides D L. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314–321
   PubMedGoogle Scholar
• Haseltine F PGM, Marchesi S, Spitz R, Dlugi A, DeCherney A A. Uterine embolization in a patient with postabortal hemorrhage. Obstet Gynecol 1984; 63: 78s–80s
   Google Scholar
• Ito M YK, Toyoda N, Wada H. Pregnancy and delivery in patients with von Willebrand's disease. J Obstet Gynecol Res 1997; 23: 37–43
   Google Scholar
• Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A, Boneu B. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 416–420
   PubMedGoogle Scholar
• Krishnamurthy M, Miotti A B. Von Willebrand's disease and pregnancy. Obstet Gynecol 1977; 49: 244–247
   Google Scholar
• Hanna W, McCarroll D, McDonald T, Painter P, Tuller J, Chen J, Lange R. Variant von Willebrand's disease and pregnancy. Blood 1981; 58: 873–879
   Google Scholar
• Takahashi H. Studies on the pathophysiology and treatment of von Willebrand's disease. VI. Variant von Willebrand's disease complicating placenta previa. Thromb Res 1983; 31: 285–296
   Google Scholar
• Takahashi H, Hayashi N, Shibata A. Type IB von Willebrand's disease and pregnancy: comparison of analytical methods of von Willebrand factor for classification of von Willebrand's disease subtypes. Thromb Res 1988; 50: 409–418
   Google Scholar
• Adashi E Y. Lack of improvement in von Willebrand's disease during pregnancy. N Engl J Med 1980; 1178
   Google Scholar
• Ramsahoye B H, Davies S V, Dasani H, Pearson J F. Pregnancy in von Willebrand's disease. J Clin Pathol 1994; 47: 569–570
   Google Scholar
• Rick M E, Williams S B, Sacher R A, McKeown L P. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood 1987; 69: 786–789
   Google Scholar
• Cohen S, Daitch J S, Amar D, Goldiner P L. Epidural analgesia for labor and delivery in a patient with von Willebrand's disease. Reg Anesth 1989; 14: 95–97
   Google Scholar
• Milaskiewicz R M, Holdcroft A, Letsky E. Epidural anaesthesia and von Willebrand's disease. Anaesthesia 1990; 45: 462–464
   Google Scholar
• Jones B P, Bell E A, Maroof M. Epidural labor analgesia in a parturient with von Willebrand's disease type IIA and severe preeclampsia. Anesthesiology 1999; 90: 1219–1220
   Google Scholar
• Takafuta T, Fujimura K, Shimomura T, et al. Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease. Int J Hematol 1994; 60: 163–172
   Google Scholar
• Watanabe T, Minakami H, Sakata Y. Successful management of pregnancy in a patient with von Willebrand disease Normandy. Obstet Gynecol 1997; 89: 859
   Google Scholar
• Caliezi C, Tsakiris D A, Behringer H, Kuhne T, Marbet G A. Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3. Haemophilia 1998; 4: 845–849
   Google Scholar
• Lipton R AAJ, Coller B S. Severe von Willebrand's disease during labor and delivery. JAMA 1982; 248: 1355–1357
   Google Scholar
• McCammon R E. Pregnancy complicated by pseudohemophilia (Von-Willebrand's disease). J Indiana State Med Assoc 1967; 60: 1363–1366
   Google Scholar
• Mullaart R A, Van Dongen P, Gabreels F J, van Oostrom C. Fetal periventricular hemorrhage in von Willebrand's disease: short review and first case presentation. Am J Perinatol 1991; 8: 190–192
   Google Scholar
• Sadan O MP, Koller A B, Hofmeyr G J. Von Willebrand's disease in pregnancy. A case report. S Afr Med J 1987; 71: 456–456
   Google Scholar
• Sorosky J KA, Nobert G F, Burchell R C. Von Willebrand's disease complicating second-trimester abortion. Obstet Gynecol 1980; 55: 253–254
   PubMed Web of Science ®Google Scholar
• Walker E HDK. The management of pregnancy in Von Willebrand's disease. J Obstet Gynaecol Br Common 1968; 75: 459–463
   Google Scholar
• Chediak J R, Alban G M, Maxey B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986; 155: 618–624
   PubMed Web of Science ®Google Scholar
• Hoyer L W, Lindsten J, Blomback M, Hagenfeldt L, Cordesius E, Stromberg P, Gustavii B. Prenatal evaluation of fetus at risk for severe von Willebrand's disease. Lancet 1979; 2: 191–192
   Google Scholar
• Thomas K B, Sutor A H, Altinkaya N, Grohmann A, Zehenter A, Leititis J U. von Willebrand factor-collagen binding activity is increased in newborns and infants. Acta Paediatr 1995; 84: 697–699
   PubMed Web of Science ®Google Scholar
• Greer I ALG, Walker J J, Forbes C D. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909–918
   PubMedGoogle Scholar